Researchers from The George Washington...
Pediatric Research
Masters Of Pediatrics
July 14, 2021
Upadacitinib Appears Effective Against Atopic Dermatitis in Teens and Adults
Two phase 3, placebo-controlled studies suggest the oral Janus kinase (JAK) inhibitor upadacitinib is effective for moderate-to-severe atopic dermatitis (AD), both alone and with topical
Childhood AD Shows Small Impact on Educational Attainment
A childhood diagnosis of atopic dermatitis was associated with lower attainment of secondary education but not higher education, according to a population-based study. “Atopic dermatitis (AD) may
Early-Life Exposure to Antibiotics Linked to Atopic Dermatitis
Exposure to antibiotics in utero and during the first year of life is associated with an increased risk for atopic dermatitis, with the correlation partially
What you Need to Know About Atopic Dermatitis
April 12, 2021 Keshav Patel, MS4 , Bernard A Cohen, MD Contemporary PEDS Journal, Vol 38 No 4, Volume 38, Issue 4 Atopic dermatitis
